Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › azathioprine

azathioprine

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of azathioprine

13 trials tracked of azathioprine: 11 in phase 3 or 4 and 7 with published results. The most-cited published study has 955 citations.

13Trials tracked
11Phase 3 & 4
0Recruiting
7With published results
Phase distribution
Phase 4 3 Phase 3 8 Phase 2 1 Phase 1 1
  1. Phase 3 A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Completed · 955 cited
  2. Phase 3 Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease Completed · 909 cited
  3. Phase 3 Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients Completed · 188 cited
  4. Phase 3 Belimumab in Remission of VASculitis Completed · 139 cited
  5. Phase 3 Rituximab Vasculitis Maintenance Study Completed · 115 cited
  6. Phase 3 A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis Completed · 37 cited
Show 7 more trials
  1. Phase 4 Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial Completed · 8 cited
  2. Phase 4 Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis Completed
  3. Phase 4 Comparison of Sirolimus and Azathioprine in Lung Transplantation Completed
  4. Phase 3 A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis. Completed
  5. Phase 3 Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis Completed
  6. Phase 2 Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis Completed
  7. Phase 1 Comparison of Efficacy of Methotrexate and Azathioprine in Patients With Chronic Actinic Dermatitis: A Randomized Controlled Trial Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Retrospective review of tocilizumab, rituximab, and azathioprine in chronic relapsing inflammatory optic neuropathy
Neurology
Retrospective review of tocilizumab, rituximab, and azathioprine in chronic relapsing inflammatory optic neuropathy New Clue Found in Stubborn Eye Inflammation
This retrospective analysis reviews tocilizumab, rituximab, and azathioprine use in 60 patients with chronic relapsing inflammatory optic ne…
Knowing a patient's blood marker status can guide doctors to the right therapy to stop recurring eye inflammation.
medRxiv Apr 23, 2026
Systematic Review and Network Meta-Analysis Compares Enteral Nutrition and Medications in Pediatric Crohn's Disease
Pediatrics Meta-analysis
Systematic Review and Network Meta-Analysis Compares Enteral Nutrition and Medications in Pediatric Crohn's Disease Exclusive nutrition therapy beats steroids for healing Crohn's in kids
This systematic review and network meta-analysis evaluates enteral nutrition versus immunomodulators and corticosteroids in 1,182 pediatric …
Exclusive nutrition therapy was far better than steroids at healing Crohn's disease in children, with fewer side effects and no serious risk…
Frontiers Apr 22, 2026
Guselkumab showed improved clinical remission in refractory ulcerative colitis versus placebo
Drug Pipeline RCT
Guselkumab showed improved clinical remission in refractory ulcerative colitis versus placebo Guselkumab shows promise for ulcerative colitis in this early phase 3 trial
This phase 3 randomized trial evaluated guselkumab in adults with moderately to severely active ulcerative colitis who had inadequate respon…
Patients with ulcerative colitis who failed other treatments achieved remission in a new trial using subcutaneous guselkumab injections.
Apr 15, 2026